Drug Trials Snapshots: VTAMA (tapinarof)

VTAMA is a small molecule aryl hydrocarbon receptor (AhR) modulating agent that is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-vtama